Cardiologists are making huge money from controversial methods to relieve limb blockages, The New York Times reports.» Read More
Tax inversion may have dominated business news headlines for months – but that could all be about to change.
A Texas college has rejected two enrollment applications from Nigerian students due to concerns of Ebola in their country, a letter suggests.
Technology is widely used in developed markets, but the size and scale of China make this a huge opportunity for tech firms and a problem for doctors.
A Chinese drug maker with close military ties is seeking fast-track approval for a drug that it says can cure Ebola.
Health officials say they are monitoring people who were in contact with the latest person to fall ill.
When courts hear arguments about the affordability of Obamacare, they should understand the reality, says health-insurance broker Tom Haynes.
Seventy-six hospital workers who treated an Ebola patient in Dallas are now being "actively monitored" for signs of the virus, a top federal health official said.
Facebook and Apple are now offering to pay for egg freezing procedures of its employees, NBC News reports.
Scam artists are hoping to bank on people's fear of Ebola, offering all kinds of products they're marketing as the latest cure.
Mark Zuckerberg donated $25 million to Center for Disease Control.
J&J reported strong earnings, boosted by sales of a new drug for hepatitis C that are expected to evaporate in coming months due to competition.
The topic everyone on Wall Street is discussing urgently but quietly isn’t the volatile stock market. It is Ebola.
A UN medical official who caught Ebola while working in Liberia died in the German hospital where he was being treated on Tuesday.
Two companies have seen their stock prices more than double in the past week thanks to speculation on Ebola worries.
National Nurses United lashed out at the CDC after the agency said a protocol breach caused a Dallas nurse to become infected with Ebola.
The World Cocoa Foundation is set to announce a fundraising initiative to help combat Ebola in West Africa.
"We have to rethink the way we address Ebola infection control because even a single infection is unacceptable," said Dr. Thomas Frieden.
NIH Director Dr. Francis Collins has it a bit wrong when he blamed government budget cuts as the reason that we don’t have an Ebola vaccine already.
Experts in the killer virus warned CNBC that airport screening was unlikely to prevent another potential victim from entering the U.S.
Steris offered to buy British sterilization services provider Synergy Health in a deal that would shift its domicile to the U.K. and cut its tax bill.
Get the best of CNBC in your inbox